HDACs — Drug Target
All drugs that target HDACs — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Marketed (1)
- Istodax · Teva Pharms Usa Inc · Histone Deacetylase Inhibitor · Oncology
Romidepsin inhibits HDACs, leading to increased acetylation of histones and non-histone proteins, causing cell cycle arrest and apoptosis in cancer cells.